X-trodes, a Tel Aviv, Israel-based bio-convergence company that developed wearable technology for advanced electrophysiological measurement and analytics, raised $4.5 million in Seed funding.
The round was led by Japan Israel High Tech Ventures (Chartered Group), Welltech. and Jeremy Coller.
Company: X-trodes Ltd
Round: Seed Round
Funding Month: October 2021
Lead Investors: Japan Israel High Tech Ventures
Additional Investors: Welltech and Jeremy Coller
Company Website: https://xtrodes.com/
Software Category: Advanced electrophysiological measurement and analytics
About the Company: Led by Ziv Peremen, co-founder and CEO, X-trodes is a bio-convergence company and the developer of the world’s first scalable wireless Smart Skin- wearable technology for advanced electrophysiological monitoring and analytics, that can be used by patients in their natural environment. The two first products that X-trodes brings to market are 1. Medical-grade sleep monitoring- a wireless system for sleep monitoring, especially for neurological and psychiatric disorders. X-trodes single patch for multi-modality measurement, retrieves meaningful insights and diagnostics from patients’ beds, in their natural environment. 2. Muscle recovery – A flexible wearable system that prevents muscle injuries and accelerates recovery by monitoring electrophysiology function in dynamic environments and analyzing every muscle with wireless AI-driven insights. The company has 12 employees.